Can Wegovy Make You Angry or Cause Mood Changes?

What the STEP 1 trial and UK regulators found

The STEP 1 trial, published in the New England Journal of Medicine, was the landmark 68-week study of semaglutide 2.4mg. It reported the medicine's safety profile in detail across roughly 1,300 participants on active treatment. Anger and aggression did not appear among the adverse effects the trial flagged as noteworthy. The side-effect profile was led by gastrointestinal symptoms (nausea, diarrhoea, constipation and vomiting) consistent with how GLP-1 receptor agonists slow gastric emptying and reduce appetite.

At a regulatory level, the MHRA's Drug Safety Update programme keeps GLP-1 medicines under active surveillance, and their published communications focus on gastrointestinal effects, pancreatitis, thyroid-related signals and (more recently) contraception interactions. Anger as a standalone effect has not prompted a specific MHRA safety communication for semaglutide. That matters: it doesn't mean it never happens to individuals, but it does mean there is no population-level signal strong enough to change the prescribing guidance.

So why do people ask? Largely because the experience of real irritability on Wegovy is genuine, even if the route to it is indirect. The distinction is worth making clearly.

The indirect routes from Wegovy to a shorter fuse

The most credible explanation for irritability during Wegovy treatment is not the drug acting on mood centres, but the downstream consequences of eating far less. When appetite drops sharply (which it does for most people starting semaglutide) caloric intake can fall quickly, sometimes faster than people realise. A dip in blood glucose, even within the normal range, can produce fatigue, poor concentration and reduced patience. That cluster of symptoms is sometimes interpreted as, or tips into, genuine irritability.

Nausea is another factor. Feeling persistently queasy, particularly in the early weeks of treatment or after a dose increase, is draining. If you're managing nausea alongside work, family or social commitments, it's unsurprising that your tolerance for everyday friction narrows. Some people also report disrupted sleep during the adjustment period, which compounds mood effects. These are real experiences; they're just not caused by semaglutide altering brain chemistry in the way a psychoactive medicine might.

Eating patterns matter here too. Protein adequacy and steady hydration are frequently emphasised alongside GLP-1 treatment, partly for this reason. If appetite suppression leads to skipping meals altogether rather than eating smaller, balanced ones, mood becomes harder to regulate. It's worth keeping a small snack in your gym bag for the early weeks, particularly on days when nausea makes a full meal unappealing.

For more on how gastrointestinal effects tend to progress, the page on whether Wegovy causes bloating and gas covers the GI picture in detail.

Mental health history: what to tell your prescriber

Wegovy's prescribing information advises that patients with a history of depression, suicidal ideation or other significant mental health conditions are assessed carefully before starting treatment. This is standard practice for any medicine that affects appetite and body weight, because the psychological relationship with eating and weight is complex. Mood changes during significant weight loss can run in both directions, many people feel better as health improves; some experience a period of adjustment that catches them off guard. If you've ever wondered whether Wegovy can actually cause weight gain, that page explores the circumstances in which the scales can move in an unexpected direction.

If you are already experiencing irritability, low mood or anxiety on Wegovy, the right step is to contact your prescriber promptly rather than managing it alone. This is especially true if the mood change feels disproportionate or persistent. At nume, our clinical team is available seven days a week for exactly this kind of aftercare question, you can reach us through our contact page. You can also report any suspected side effect, including mood changes, directly to the MHRA via the Yellow Card scheme.

People sometimes ask whether irritability or mood changes are a reason to stop treatment. That is a clinical decision, not a self-managed one. A prescriber can assess whether the symptom relates to the medicine, to reduced intake, or to something unrelated, and can advise whether to continue, adjust or pause.

For a broader look at the reported psychological experience of semaglutide, the page on whether semaglutide causes anger covers the overlapping evidence in more depth. If you're thinking about what Wegovy treatment involves overall, our Wegovy overview sets out how it works, who it suits and what to expect.

When a prescriber should know straight away

Most irritability linked to Wegovy settles as appetite and eating patterns stabilise, usually within the first few weeks. But there are circumstances where a prescriber needs to know the same day, not at the next routine check-in.

Contact your prescriber promptly if you experience: low mood or depression that feels new or worsening; thoughts of self-harm or suicide; mood swings that are interfering with daily life or relationships; or any mental health symptom that appeared or intensified after starting or increasing your dose. These are not necessarily caused by semaglutide, but they need clinical attention regardless of cause. People with questions about how the medicine interacts with the body more broadly, including those who have read about whether semaglutide can be made at home or compounded, should discuss any concerns with a qualified prescriber before making changes to their treatment. It is also worth being aware that Wegovy can affect your menstrual cycle, something worth raising with your prescriber if you notice changes alongside any mood symptoms.

The NHS patient information for semaglutide, available on the NHS medicines page for semaglutide, lists mental health changes among the effects worth reporting to a doctor. Read it alongside your Patient Information Leaflet, which is the definitive guide to your specific prescription.

Weight-loss treatment is a long-term commitment. The clinical relationship matters throughout, not just at the start. If you haven't yet had a consultation and want to discuss your history (including any mental health concerns) with a qualified prescriber, starting with a free consultation at nume means a real clinician reviews your answers the same day.